- Bibliography
- Subscribe
- News
-
Referencing guides Blog Automated transliteration Relevant bibliographies by topics
Log in
Українська Français Italiano Español Polski Português Deutsch
We are proudly a Ukrainian website. Our country was attacked by Russian Armed Forces on Feb. 24, 2022.
You can support the Ukrainian Army by following the link: https://u24.gov.ua/. Even the smallest donation is hugely appreciated!
Relevant bibliographies by topics / Pharmacist-Provided / Journal articles
To see the other types of publications on this topic, follow the link: Pharmacist-Provided.
Author: Grafiati
Published: 4 June 2021
Last updated: 4 February 2022
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Pharmacist-Provided.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
1
Yap, Diana. "CMS report affirms pharmacist-provided MTM." Pharmacy Today 19, no.11 (November 2013): 44. http://dx.doi.org/10.1016/s1042-0991(15)31105-1.
Full textAPA, Harvard, Vancouver, ISO, and other styles
2
Doucette,WilliamR., MatthewJ.Witry, KarenB.Farris, and RandalP.Mcdonough. "Community Pharmacist–Provided Extended Diabetes Care." Annals of Pharmacotherapy 43, no.5 (April28, 2009): 882–89. http://dx.doi.org/10.1345/aph.1l605.
Full textAbstract:
Background Pharmacists in various settings have been effective in initiating diabetes treatment. Patients with diabetes require ongoing disease management, and community pharmacists are in a strategic position to provide such extended care. Little is known, however, about the effects of community pharmacist–provided interventions beyond the initial treatment period. Objective To evaluate the effect of community pharmacist–provided extended diabetes care service on primary clinical outcomes, including hemoglobin A1c (A1C), low-density lipoprotein cholesterol (LDL-C), and blood pressure, and on patients' reported self-care activities. Methods A randomized controlled trial was conducted in patients with diabetes. Participants had already completed at least 2 diabetes education sessions at a local diabetes education center. Nine specially trained pharmacists administered interventions during up to 4 quarterly visits per patient. Interventions included discussing medications, clinical goals, and self-care activities with patients and recommending medication changes to physicians when appropriate. The main outcome measures were 12-month changes in A1C, LDL-C, blood pressure, and self-report of self-care activities. Results Seventy-eight patients participated in the study (36 intervention, 42 control); 66 were included in the final analysis (31 intervention, 35 control). Compared with changes in the control group, patients who received interventions significantly increased the number of days per week that they engaged in a set of diet and diabetes self-care activities (1.25 and 0.73 more days/wk, respectively). The mean 12-month changes for A1C, LDL-C, and blood pressure were not significantly different between the 2 study groups. Conclusions Although pharmacist-provided interventions did not demonstrate statistically significant improvements in clinical outcomes over the study period, study results did show that pharmacists were effective at increasing the number of days that patients spent engaging in healthy diet and diabetes self-care activities. Addressing lifestyle and self-care behaviors can be a beneficial component of a pharmacist-provided extended diabetes care service.
APA, Harvard, Vancouver, ISO, and other styles
3
McDonough,RandyP. "Creating capacity for pharmacist-provided patient care." Pharmacy Today 22, no.3 (March 2016): 54. http://dx.doi.org/10.1016/j.ptdy.2016.02.025.
Full textAPA, Harvard, Vancouver, ISO, and other styles
4
Bonner, Loren. "Pharmacist-provided MTM telehealth services catch on." Pharmacy Today 22, no.8 (August 2016): 56. http://dx.doi.org/10.1016/j.ptdy.2016.07.030.
Full textAPA, Harvard, Vancouver, ISO, and other styles
5
McDonough,RandyP. "Understanding payers’ perspective on pharmacist-provided MMS." Pharmacy Today 22, no.9 (September 2016): 37. http://dx.doi.org/10.1016/j.ptdy.2016.08.021.
Full textAPA, Harvard, Vancouver, ISO, and other styles
6
Saunders,ShawnM., JohnA.Tierney, JaneM.Forde, AnthonyV.Onorato, and MartyH.Abramson. "Implementing a pharmacist-provided discharge counseling service." American Journal of Health-System Pharmacy 60, no.11 (June1, 2003): 1101. http://dx.doi.org/10.1093/ajhp/60.11.1101.
Full textAPA, Harvard, Vancouver, ISO, and other styles
7
Nguyen, Elaine, and JohnT.Holmes. "Pharmacist-provided services: Barriers to demonstrating value." Journal of the American Pharmacists Association 59, no.1 (January 2019): 117–20. http://dx.doi.org/10.1016/j.japh.2018.11.007.
Full textAPA, Harvard, Vancouver, ISO, and other styles
8
Valentino, Alexa Sevin, Emily Eddy, Zachary Woods, and Lori Wilken. "Pharmacist Provided Spirometry Services: A Scoping Review." Integrated Pharmacy Research and Practice Volume 10 (August 2021): 93–111. http://dx.doi.org/10.2147/iprp.s248705.
Full textAPA, Harvard, Vancouver, ISO, and other styles
9
Erickson,AmyK. "A new avenue for revenue: Pharmacist-provided AWVs." Pharmacy Today 20, no.9 (September 2014): 54. http://dx.doi.org/10.1016/s1042-0991(15)30711-8.
Full textAPA, Harvard, Vancouver, ISO, and other styles
10
Klepser, Donald. "Role of pharmacist-provided point-of-care testing." Journal of the American Pharmacists Association 55, no.6 (November 2015): 573–74. http://dx.doi.org/10.1016/s1544-3191(16)30017-6.
Full textAPA, Harvard, Vancouver, ISO, and other styles
11
McCants, Hilary. "Role of pharmacist-provided point-of-care testing." Journal of the American Pharmacists Association 55, no.6 (November 2015): 574–76. http://dx.doi.org/10.1016/s1544-3191(16)30018-8.
Full textAPA, Harvard, Vancouver, ISO, and other styles
12
Rodis,JenniferL., JonC.Schommer, and MichelleA.Maguire. "Building capacity for pharmacist-provided patient care services." Journal of the American Pharmacists Association 51, no.1 (January 2011): 10–14. http://dx.doi.org/10.1331/japha.2011.11500.
Full textAPA, Harvard, Vancouver, ISO, and other styles
13
Kuhn,CatherineH. "Role of pharmacist-provided point-of-care testing." Journal of the American Pharmacists Association 55, no.6 (November 2015): 572–73. http://dx.doi.org/10.1331/japha.2015.15549.
Full textAPA, Harvard, Vancouver, ISO, and other styles
14
Pherson, Emily, Meghan Swarthout, Denise Fu, Lauren Barbour, Robert Green, Patricia Ross, and Todd Nesbit. "Medication management through pharmacist-provided home-based services." Journal of the American College of Clinical Pharmacy 3, no.4 (April29, 2020): 749–56. http://dx.doi.org/10.1002/jac5.1225.
Full textAPA, Harvard, Vancouver, ISO, and other styles
15
Donihi, Amy Calabrese, Eunjin Yang, ScottM.Mark, CarlA.Sirio, and RobertJ.Weber. "Scheduling of Pharmacist-Provided Medication Education for Hospitalized Patients." Hospital Pharmacy 43, no.2 (February 2008): 121–26. http://dx.doi.org/10.1310/hpj4302-121.
Full textAPA, Harvard, Vancouver, ISO, and other styles
16
Collum,JessicaL., ToddR.Marcy, EricL.Stevens, CraigF.Burns, and MichaelJ.Miller. "Exploring patient expectations for pharmacist-provided literacy-sensitive communication." Research in Social and Administrative Pharmacy 9, no.5 (September 2013): 626–32. http://dx.doi.org/10.1016/j.sapharm.2012.05.012.
Full textAPA, Harvard, Vancouver, ISO, and other styles
17
Johnson,CarrieL., Amy Nicholas, Holly Divine, DonaldG.Perrier, Karen Blumenschein, and DouglasT.Steinke. "Outcomes from DiabetesCARE: A pharmacist-provided diabetes management service." Journal of the American Pharmacists Association 48, no.6 (November 2008): 722–30. http://dx.doi.org/10.1331/japha.2008.07133.
Full textAPA, Harvard, Vancouver, ISO, and other styles
18
Darin,KristinM., MichaelE.Klepser, DonaldE.Klepser, StephanieA.Klepser, Andrew Reeves, Maria Young, and KimberlyK.Scarsi. "Pharmacist-provided rapid HIV testing in two community pharmacies." Journal of the American Pharmacists Association 55, no.1 (January 2015): 81–88. http://dx.doi.org/10.1331/japha.2015.14070.
Full textAPA, Harvard, Vancouver, ISO, and other styles
19
Schommer,JonC., WilliamR.Doucette, and LourdesG.Planas. "Establishing pathways for access to pharmacist-provided patient care." Journal of the American Pharmacists Association 55, no.6 (November 2015): 664–68. http://dx.doi.org/10.1331/japha.2015.15029.
Full textAPA, Harvard, Vancouver, ISO, and other styles
20
Jennifer, Anderson, NeetaK.Venepalli, Patrick Joseph Fleming, Christina Haaf, Adam Bursua, Little Irene Park, and Sandra Cuellar. "Documentation of pharmacist-provided patient education for oral chemotherapy." Journal of Clinical Oncology 34, no.7_suppl (March1, 2016): 237. http://dx.doi.org/10.1200/jco.2016.34.7_suppl.237.
Full textAbstract:
237 Background: Pharmacist-provided patient education for oral chemotherapy is poorly documented in patient electronic medical records (EMR) at UIC Oncology Pharmacy. At baseline, 41% of patients who started new therapy with selected oral chemotherapies had a patient education note documented by a pharmacist in their EMR. Our aim is to provide and document patient education for at least 90% of patients who start new oral chemotherapy and fill their prescriptions at UIC Oncology Pharmacy over three months. The importance of patient counseling and documentation is recognized by the Quality Oncology Practice Initiative (QOPI) group. Approximately 25% of patients undergoing chemotherapy are on oral chemotherapy. (Deutsch S, Koerner P, Miller RT, Craft Z, Fancher K. Utilization patterns for oral oncology medications in a specialty pharmacy cycle management program. J Oncol Pharm Pract. 2014;0:1-8.) Methods: A multi-disciplinary team performed an affinity sort and created a process map to identify areas of intervention. The first intervention was labelling prescription bags to identify them as oral chemotherapy prescriptions that require counseling by a pharmacist. Data was collected after two weeks. Results: At the completion of the first PDSA cycle, 40% of patients who started new oral chemotherapy had a documented patient education note written by a pharmacist in their EMR. Documentation of education was performed on the day of pick-up in 89% of cases. Table 1 shows the percentage of notes that included the elements recognized by QOPI standards: documentation of start date, adherence, and adverse effects. Conclusions: Documentation of patient education for oral chemotherapy should be a well-integrated component of ambulatory pharmacy practice. A second PDSA cycle is planned to increase rates of documentation by utilizing the pharmacy resident to perform patient counseling and documentation. Future interventions will be aimed at improving the quality of the data included in the documented notes. [Table: see text]
APA, Harvard, Vancouver, ISO, and other styles
21
Hunter,KimberlyA., and BobbyG.Bryant. "Pharmacist provided education and counseling for managing pediatric asthma." Patient Education and Counseling 24, no.2 (October 1994): 127–34. http://dx.doi.org/10.1016/0738-3991(94)90006-x.
Full textAPA, Harvard, Vancouver, ISO, and other styles
22
Merrill,BradleyS., CaseyR.Tak, Michael Feehan, and MarkA.Munger. "Payers’ Perspectives on Pharmacist-Directed Care in a Community Pharmacy Setting." Annals of Pharmacotherapy 53, no.9 (March21, 2019): 916–21. http://dx.doi.org/10.1177/1060028019839440.
Full textAbstract:
Background: The United States is spending an increasing share of its national income on health care while American citizens are not receiving the commensurate benefit of longer, healthier lives. Pharmacists are in a position to provide high-quality care; however, a paucity of data exists on payers’ perspectives on insurance reimbursement for pharmacist-provided, community-delivered clinical services. Objective: To understand payers’ perspectives toward pharmacist-provided community-delivered advanced clinical services. Methods: A 15-minute online survey was administered to determine payers’ preferences and attitudes of impact about care being provided in a community pharmacy setting by a pharmacist. Results: The study recruited 50 payers from a diverse set of US organizations. The likelihood for reimbursement for a suite of pharmacist-provided, community-delivered clinical services was likely/very likely (66%), neutral (22%), and unlikely/very unlikely (12%). Pharmacists were viewed positively by payers for the provision of these services. Payers think that more clinical services should be offered in the community pharmacy. Trust in pharmacist-provided information services on general health and medications, and pharmacist competency were strongly positive. Conclusions and Relevance: A quantitative assessment of payer attitudes for pharmacist-provided, community-delivered advanced clinical practice was positive. Payers were positive about pharmacist contributions to the provision of heath and medication information. Continued development and deployment of advanced clinical services at the community pharmacy appears to be a financially viable model.
APA, Harvard, Vancouver, ISO, and other styles
23
Gugkaeva,Z., J.S.Crago, and M.Yasnogorodsky. "Next step in antibiotic stewardship: Pharmacist-provided penicillin allergy testing." Journal of Clinical Pharmacy and Therapeutics 42, no.4 (May14, 2017): 509–12. http://dx.doi.org/10.1111/jcpt.12530.
Full textAPA, Harvard, Vancouver, ISO, and other styles
24
Baxter, Michael. "New opportunities under MACRA set stage for pharmacist-provided care." Pharmacy Today 23, no.1 (January 2017): 46. http://dx.doi.org/10.1016/j.ptdy.2016.12.026.
Full textAPA, Harvard, Vancouver, ISO, and other styles
25
Hatton, Jessica, Rachel Chandra, David Lucius, and Elizabeth Ciuchta. "Patient Satisfaction of Pharmacist-Provided Care via Clinical Video Teleconferencing." Journal of Pharmacy Practice 31, no.5 (July13, 2017): 429–33. http://dx.doi.org/10.1177/0897190017715561.
Full textAbstract:
Purpose: Patient satisfaction with the use of telehealth in disease state management provided by pharmacists has not been fully studied. We hypothesized that patient satisfaction with pharmacist-provided consultations via clinical video teleconferencing (CVT) would not differ from face-to-face delivery. Methods: Patients were recruited from 2 primary care provider sites from September 2015 to May 2016. Patients completed a survey to evaluate their satisfaction and quality of provider–patient communication with the method in which consultation with a pharmacist was provided. The survey was a 10-item, patient self-reported questionnaire. The primary outcome evaluated patients’ scores on assessment of the provider’s use of patient-centered communication. The secondary outcome evaluated patients’ scores on assessment of the provider’s clinical competence and skills and interpersonal skills. Results: There were a total of 57 surveys collected. For both the primary outcome and secondary outcome, over 80% of collected responses for each question in both clinics were scored a 5 that indicates patients were very satisfied with the provider’s use of patient-centered communication and clinical competence and skills. For both the primary and secondary outcomes, there were no statistically significant differences in patients’ scores that assessed provider’s use of patient-centered communication nor the provider’s clinical competence and skill. Conclusion: The results of this study indicate patients are satisfied with pharmacists’ use of patient-centered communication and clinical competence and skills via both CVT and face-to-face consultations supporting our research hypothesis that patient satisfaction with care provided via CVT did not differ from face-to-face provided care.
APA, Harvard, Vancouver, ISO, and other styles
26
McGrath, Stephanie Harriman, MargieE.Snyder, Gladys Garcia Dueñas, JaniceL.Pringle, RandallB.Smith, and Melissa Somma McGivney. "Physician perceptions of pharmacist-provided medication therapy management: Qualitative analysis." Journal of the American Pharmacists Association 50, no.1 (January 2010): 67–71. http://dx.doi.org/10.1331/japha.2010.08186.
Full textAPA, Harvard, Vancouver, ISO, and other styles
27
Shane-McWhorter, Laura, Carrie McAdam-Marx, Leslie Lenert, Marta Petersen, Sarah Woolsey, JeffreyM.Coursey, ThomasC.Whittaker, et al. "Pharmacist-provided diabetes management and education via a telemonitoring program." Journal of the American Pharmacists Association 55, no.5 (September 2015): 516–26. http://dx.doi.org/10.1331/japha.2015.14285.
Full textAPA, Harvard, Vancouver, ISO, and other styles
28
Liko, Ina, Lisa Corbin, Eric Tobin, ChristinaL.Aquilante, and Yee Ming Lee. "Implementation of a pharmacist-provided pharmacogenomics service in an executive health program." American Journal of Health-System Pharmacy 78, no.12 (March27, 2021): 1094–103. http://dx.doi.org/10.1093/ajhp/zxab137.
Full textAbstract:
Abstract Purpose We describe the implementation of a pharmacist-provided pharmacogenomics (PGx) service in an executive health program (EHP) at an academic medical center. Summary As interest in genomic testing grows, pharmacists have the opportunity to advance the use of PGx in EHPs, in collaboration with other healthcare professionals. In November 2018, a pharmacist-provided PGx service was established in the EHP at the University of Colorado Hospital. The team members included 3 physicians, a pharmacist trained in PGx, a registered dietitian/exercise physiologist, a nurse, and 2 medical assistants. We conducted 4 preimplementation steps: (1) assessment of the patient population, (2) selection of a PGx test, (3) establishment of a visit structure, and (4) selection of a billing model. The PGx consultations involved two 1-hour visits. The first visit encompassed pretest PGx education, review of the patient’s current medications and previous medication intolerances, and DNA sample collection for genotyping. After this visit, the pharmacist developed a therapeutic plan based on the PGx test results, discussed the results and plan with the physician, and created a personalized PGx report. At the second visit, the pharmacist reviewed the PGx test results, personalized the PGx report, and discussed the PGx-guided therapeutic plan with the patient. Overall, the strategy worked well; minor challenges included evaluation of gene-drug pairs with limited PGx evidence, communication of information to non-EHP providers, scheduling issues, and reimbursement. Conclusion The addition of a PGx service within an EHP was feasible and provided pharmacists the opportunity to lead PGx efforts and collaborate with physicians to expand the precision medicine footprint at an academic medical center.
APA, Harvard, Vancouver, ISO, and other styles
29
Bouwmeester, Carla, Jacqueline Kraft, and KathleenM.Bungay. "Optimizing inhaler use by pharmacist-provided education to community-dwelling elderly." Respiratory Medicine 109, no.10 (October 2015): 1363–68. http://dx.doi.org/10.1016/j.rmed.2015.07.013.
Full textAPA, Harvard, Vancouver, ISO, and other styles
30
Peters, Sondra, Dana Singla, and Erin Raney. "Impact of Pharmacist-Provided Osteoporosis Education and Screening in the Workplace." Journal of the American Pharmacists Association 46, no.2 (March 2006): 216–18. http://dx.doi.org/10.1016/s1544-3191(15)31564-8.
Full textAPA, Harvard, Vancouver, ISO, and other styles
31
Moczygemba,LeticiaR., JamieC.Barner, CarolynM.Brown, KennethA.Lawson, EvelynR.Gabrillo, Paul Godley, and Michael Johnsrud. "Patient satisfaction with a pharmacist-provided telephone medication therapy management program." Research in Social and Administrative Pharmacy 6, no.2 (June 2010): 143–54. http://dx.doi.org/10.1016/j.sapharm.2010.03.005.
Full textAPA, Harvard, Vancouver, ISO, and other styles
32
Peak,VincentJ., StanA.Greene, Lea Ann Hansen, and CliffordE.Hynniman. "Twenty-four-hour clinical services provided by an on-call pharmacist." American Journal of Health-System Pharmacy 43, no.7 (July1, 1986): 1753–54. http://dx.doi.org/10.1093/ajhp/43.7.1753.
Full textAPA, Harvard, Vancouver, ISO, and other styles
33
Sansgiry, SS, DJ Hayes, GK Rice, AT Nadrash, KE Erickson, and MU Bui. "PHP2: ATTITUDE OF PHYSICIANS TOWARD FORMULARIES AND SERVICES PROVIDED BY PHARMACIST." Value in Health 4, no.2 (September 2001): 168–69. http://dx.doi.org/10.1046/j.1524-4733.2001.40202-262.x.
Full textAPA, Harvard, Vancouver, ISO, and other styles
34
Ni, Weiyi, Danielle Colayco, Jonathan Hashimoto, Kevin Komoto, Chandrakala Gowda, Bruce Wearda, and Jeffrey McCombs. "Budget Impact Analysis of a Pharmacist-Provided Transition of Care Program." Journal of Managed Care & Specialty Pharmacy 24, no.2 (February 2018): 90–96. http://dx.doi.org/10.18553/jmcp.2018.24.2.90.
Full textAPA, Harvard, Vancouver, ISO, and other styles
35
Currie,JayD., WilliamR.Doucette, Julie Kuhle, Jenelle Sobotka, WilliamA.Miller, RandalP.McDonough, and AngelaL.Tice. "Identification of Essential Elements in the Documentation of Pharmacist-Provided Care." Journal of the American Pharmaceutical Association (1996) 43, no.1 (January 2003): 41–49. http://dx.doi.org/10.1331/10865800360467033.
Full textAPA, Harvard, Vancouver, ISO, and other styles
36
Peters, Sondra, Dana Singla, and Erin Raney. "Impact of Pharmacist-Provided Osteoporosis Education and Screening in the Workplace." Journal of the American Pharmacists Association 46, no.2 (March1, 2006): 216–18. http://dx.doi.org/10.1331/154434506776180603.
Full textAPA, Harvard, Vancouver, ISO, and other styles
37
Schommer,JonC., LourdesG.Planas, KathleenA.Johnson, and WilliamR.Doucette. "Pharmacist-provided medication therapy management (part 1): Provider perspectives in 2007." Journal of the American Pharmacists Association 48, no.3 (May 2008): 354–63. http://dx.doi.org/10.1331/japha.2008.08012.
Full textAPA, Harvard, Vancouver, ISO, and other styles
38
schommer,JonC., LourdesG.Planas, KathleenA.Johnson, and WilliamR.Doucette. "Pharmacist-provided medication therapy management (part 2): Payer perspectives in 2007." Journal of the American Pharmacists Association 48, no.4 (July 2008): 478–86. http://dx.doi.org/10.1331/japha.2008.08023.
Full textAPA, Harvard, Vancouver, ISO, and other styles
39
Malpani, Ashok kumar, Shivani Vulkundakar, Riyaz Miya, Karan Kamble, and M.Gouthami. "Impact of pharmacist provided knowledge on dengue among selected school children." International Journal of Research in Hospital and Clinical Pharmacy 1, no.1 (September11, 2018): 1–10. http://dx.doi.org/10.33974/ijrhcp.v1i1.15.
Full textAbstract:
Background: Dengue is a self-limiting acute mosquito transmitted disease caused by an arbovirus and spread by Aedes mosquitoes, sever infections results in DHF & DSS. Hence school education has been described as a ‘social vaccine’, and it can serve as a powerful preventive tool. Aim & Objectives: To assess the prevalence of mosquito borne diseases among School children, to assess the knowledge level of high school children regarding dengue and its prevention before and after the administration of planned teaching programme and to provide health education regarding dengue fever among school children. Materials and Methods: A six months’ community based prospective observational study was conducted at selected schools of Gulbarga District. Total of 265 students were enrolled into the study by considering study criteria. Our inclusion criteria are all students of secondary school students of class 8th -10th. The data was collected from school children of RGEMS & AEMS in Gulbarga district. Results: In our study, most of the students were unaware of insect and species of mosquito which is responsible for causing DF, DHS & DSS and their knowledge was found to be excellent 3.6%, good 33.46%, average 37.90% and poor 25.00% before providing the knowledge. We pharmacist in our study played a vital role in providing education to the school children and their knowledge progress after our study was found, excellent 69.23%, good 30.76% and none of the students had average and poor knowledge. Conclusion: Our study concludes that the educational interventions by the pharmacist plays a vital role by educating the students and their by improving theirs and surrounding community health. Hence it is very imperative for pharmacists and other health care disciplinarians to carry out community based studies or educational interventions at all levels of students particularly in rural India where there is scope to improve their knowledge which helps students their parents and siblings and surrounding community.
APA, Harvard, Vancouver, ISO, and other styles
40
Stergachis, Andy. "Strengthening the evidence-base on payment models for pharmacist-provided services." Journal of the American Pharmacists Association 59, no.1 (January 2019): 5. http://dx.doi.org/10.1016/j.japh.2018.12.016.
Full textAPA, Harvard, Vancouver, ISO, and other styles
41
Iancu, Mihaela Ela, Camelia Bucsa, Andreea Maria Farcas, Daniel Corneliu Leucuta, Adriana Dincu, and Marius Traian Bojita. "Counseling provided by the pharmacist in Romanian community pharmacy: the patients’ perspective." Medicine and Pharmacy Reports 87, no.2 (July1, 2014): 113–18. http://dx.doi.org/10.15386/cjmed-257.
Full textAbstract:
Background and aims. Patient education is a critical task that may be carried out by the pharmacists, especially in the context of contemporary pharmacists’ roles, which tend to be closer to patients and their needs. This study aimed to evaluate the counseling provided by the pharmacist in the community pharmacy, from the patient’s perspective.Patients and methods. We conducted a prospective, non-interventional study in 520 pharmacies from 10 Romanian counties across the country. The first 10 visitors of the pharmacy on a given day were asked to complete a questionnaire regarding the counseling provided by the pharmacist during the visit.Results. More than 90% of patients received advice from the pharmacist on the route of administration, use in relation to meals, dosage and length of treatment. More than 80% of the patients were counseled on the medicine contraindications and precautions, interactions with other medicines and food, side effects, additional changes in lifestyle and diet appropriate to the condition and the necessity to immediately consult a doctor/pharmacist in case of adverse drug reactions. Lower percentages were registered for advising the patient on the obligation to return to pharmacy the unused psychotropic drugs (38.04%) and the ability of the drug to modify the laboratory results (47.66).Conclusions. The results of the present study showed that the counseling activity in the community pharmacy is carried out by the pharmacists in a high proportion, according to the patients’ feedback.
APA, Harvard, Vancouver, ISO, and other styles
42
Branham,AshleyR., AaronJ.Katz, JosephS.Moose, StefanieP.Ferreri, JoelF.Farley, and MacaryW.Marciniak. "Retrospective Analysis of Estimated Cost Avoidance Following Pharmacist-Provided Medication Therapy Management Services." Journal of Pharmacy Practice 26, no.4 (November25, 2012): 420–27. http://dx.doi.org/10.1177/0897190012465992.
Full textAbstract:
Objective: To compare the estimated cost avoidance (ECA) of pharmacist-provided medication therapy management (MTM) services among common disease states encountered in community pharmacy practice. Design: Retrospective analysis. Setting: Nine community pharmacies in North Carolina. Patients: Three hundred and sixty-four patients who are 65 years of age or older, a Medicare Part D beneficiary and a North Carolina resident. Interventions: An MTM pharmacist-provider conducted medication reviews to eligible patients between July 2009 and October 2009. For each encounter, patient interventions, pharmacist recommendations, and ECA were recorded. Main outcome measure: ECA. Results: In 9 pharmacy locations, 634 MTM interventions were documented during the study period. The ECA in a 4-month period yielded approximately $494 000. Comprehensive medication reviews, new prescription counseling and appropriate medication administration, and technique counseling made up nearly two-thirds of interventions. Overall, the probability that an MTM intervention would result in an ECA greater than $0 was .35. Conclusions: Pharmacist-provided MTM effectively reduced costs associated with patient medication use. Such interventions reduced costs in overall health care specifically in the areas of cardiovascular, gastroesophageal reflux disease, pulmonary, and diabetes groups.
APA, Harvard, Vancouver, ISO, and other styles
43
P, Deekshitha, DhivyaK, LakshmiPrasannaS, and AnushaT. "Impact of pharmacist provided counseling on mental health status of postmenopausal Women." International Journal of Research in Pharmaceutical Sciences 9, no.1 (March12, 2018): 109. http://dx.doi.org/10.26452/ijrps.v9i1.1199.
Full textAbstract:
Menopause is described as the point of time when the last menstruation occurs in a woman. This is the period during which changes in the bleeding patterns due to alterations in the hormone levels were noticed. Due to alterations in these hormone levels, physical as well as mental health changes occur in women resulting in menopausal symptoms. Hence, this study was conducted to analyze the impact of counseling on MHS of postmenopausal women. This simple prospective interventional study was conducted in the Gynecology department of Tertiary Care Hospital for a period of 4 months in 200 patients divided into two groups. Mental health status (MHS) scores were calculated by using a validated questionnaire. Statistically significant difference in the score of baseline MHS was found between the two groups. Reduction in the score of MHS was seen in both the groups after counseling. Thus, this study revealed that providing counseling to postmenopausal women has positive impact on their mental health. Therefore, rendering effectual and repeated counseling to menopausal women depends on their need assist in leading a happy moreover healthy life. Keywords: Post menopause; Estrogen deficiency Mental health; Counseling
APA, Harvard, Vancouver, ISO, and other styles
44
Naseman, Kristina Wood, AndrewS.Faiella, and GarrettM.Lambert. "Pharmacist-Provided Diabetes Education and Management in a Diverse, Medically Underserved Population." Diabetes Spectrum 33, no.2 (March16, 2020): 210–14. http://dx.doi.org/10.2337/ds19-0048.
Full textAPA, Harvard, Vancouver, ISO, and other styles
45
Xuan,S., D.Colayco, J.Hashimoto, K.Komoto, and J.S.McCombs. "PMU67 IMPACT OF PHARMACIST-PROVIDED TRANSITION OF CARE SERVICES ON HOSPITAL READMISSIONS." Value in Health 23 (May 2020): S245. http://dx.doi.org/10.1016/j.jval.2020.04.837.
Full textAPA, Harvard, Vancouver, ISO, and other styles
46
Pinto,S., G.Partha, M.Ferrell, B.Coehrs, and C.Riepenhoff. "PDB57 IMPROVING CLINICAL OUTCOMES FOR EMPLOYEES PARTICIPATING IN A PHARMACIST PROVIDED MTM." Value in Health 13, no.3 (May 2010): A65. http://dx.doi.org/10.1016/s1098-3015(10)72302-0.
Full textAPA, Harvard, Vancouver, ISO, and other styles
47
Barnett,CandaceW. "Need for Community Pharmacist–Provided Food-Allergy Education and Autoinjectable Epinephrine Training." Journal of the American Pharmacists Association 45, no.4 (July 2005): 479–85. http://dx.doi.org/10.1331/1544345054475432.
Full textAPA, Harvard, Vancouver, ISO, and other styles
48
Rafferty, Aubrie, Sheri Denslow, and Elizabeth Landrum Michalets. "Pharmacist-Provided Medication Management in Interdisciplinary Transitions in a Community Hospital (PMIT)." Annals of Pharmacotherapy 50, no.8 (June5, 2016): 649–55. http://dx.doi.org/10.1177/1060028016653139.
Full textAPA, Harvard, Vancouver, ISO, and other styles
49
Westrick,SalisaC., LindseyA.Hohmann, and TessaJ.Hastings. "Pharmacy technicians—A critical element to facilitate implementation of pharmacist-provided services." Journal of the American Pharmacists Association 58, no.2 (March 2018): 133–34. http://dx.doi.org/10.1016/j.japh.2018.02.008.
Full textAPA, Harvard, Vancouver, ISO, and other styles
50
El-Kurdi, Raisa, LauraA.Rhodes, AmyD.Sauls, Rachel Selinger, John Taylor Schimmelfing, AnnN.Chelminski, ChristineS.Goodman, and Macary Weck Marciniak. "Assessing barriers to patient acceptance of pharmacist-provided recommendations for international travel." Journal of the American Pharmacists Association 59, no.4 (July 2019): S72—S76. http://dx.doi.org/10.1016/j.japh.2019.04.021.
Full textAPA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!